Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on EVERYMAN MEDIA GROUP PLC. We currently have 4 research reports from 2 professional analysts.
|21Feb17 07:00||RNS||New Opening and Related Party Transactions|
|10Jan17 16:00||RNS||Grant of Options|
|10Jan17 07:00||RNS||Trading Update|
|14Sep16 07:00||RNS||Half-year Report|
|26Jul16 07:00||RNS||Change of Auditor|
|11Jul16 07:00||RNS||Trading Update|
|06Jun16 15:22||RNS||Holding(s) in Company|
Frequency of research reports
Research reports on
EVERYMAN MEDIA GROUP PLC
EVERYMAN MEDIA GROUP PLC
15 Sep 16
"With polls narrowing enough to suggest that Clinton’s lead over Trump ahead of the November 8th presidential election is now just 3 points, traders have finally started to ask the unanswerable - which will be the winners and losers? Quite a quandary. Market anticipation of the Republican candidate winning would be a severe heightening of the market’s greatest phobia, uncertainty and rising risk aversion. The first signs of this were evident overnight, not helped by FOMC conflict seemingly projecting stalemate at the Fed, as the US$ fell and bonds gained. This, in fact, follows the established historical pattern of the currency reacting more favourably to a Democrat in the White House. US equities that started their session strongly, gave nearly everything back by the close with only the tech-heavy NASDAQ registering a reasonable gain while energy stocks continued to weaken following continued US inventory build, the IEA report that foresaw the current supply glut continuing into 2017 and whose argument is being boosted by news of planned export resumption from both Libya and Nigeria. Asia was similarly mixed with the Nikkei the principal casualty on the back of stronger Yen due to forex traders switching US$ positions, while China was closed and gently selling of commodity stocks weakened the ASX. A number of market sensitive macro releases are due today, including the Eurozone inflation report and retail sales data from both the UK and the US. UK corporates due to report earnings include Morrisons (MRW.L), Next (NXT.L), Ophir Energy (OPHR.L), Tribal Group (TRB.L) and a Q2’16 update from Booker Group (BOK.L). Later in the UK trading session, the Bank of England is also due to disclose its rate interest decision; having told the markets last week that “we are very much not out of ammunition, nor are we trigger happy” Governor Mark Carney effectively added to traders’ growing doubts regarding the effectiveness of prospective central bank policy against a global backdrop of weakening growth. No change in the UK base rate is expected today. The FTSE-100 is seen down some 20 points in early morning trade. " - Barry Gibb, Research Analyst
20 Feb 17
Hayward Tyler Group* (HAYT): Trading update and financial position (CORP) | Petra Diamonds (PDL): Interim results (BUY) | Gemfields* (GEM): Interim results (CORP) | Premaitha Health* (NIPT): Middle East momentum (CORP) | Sound Energy (SOU): Acquisition update and TE-8 well spud (HOLD) | Proactis* (PHD): Interim trading on track (CORP) | 7digital* (7DIG): Automotive contract win (CORP)
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
N+1 Singer - Morning Song 22-02-2017
22 Feb 17
CORETX (COR LN) Contract wins and new Lifestyle facility | Gooch & Housego (GHH LN) Solid Q1 trading plus earnings enhancing acquisition of StingRay Optics | NCC Group (NCC LN) Further issues in Assurance | PCI-PAL (PCIP LN) Strong H1 underpins positive outlook | UBM (UBM LN) Results | Verona Pharma (VRP LN) Phase IIa RPL554 add-on trial to tiotropium commenced
N+1 Singer - CVS Group - Strong AGM prompts double-digit upgrades
24 Nov 16
CVS has issued a strong AGM statement which further justifies its premium rating. For the first 4 months to October it has traded “ahead of the Board’s expectations”, registering an impressive 6.3% LFL showing. It has also been busy consolidating and established a foothold in the Dutch market. We push through 10% EPS upgrades for each of the next 3 years and see further upside risk. The strength of the update shows CVS continues to have strong momentum and we argue for fair value towards 1100p.
N+1 Singer - Gym Group - Not quite a lean, fit & healthy outlook
15 Feb 17
Gym Group has done an excellent job in successfully rolling out a disruptive business model in the health & fitness market. However, we think growth expectations are too high and the shares look expensive on a FY17 P/E of 27x. We expect initial signs of increased competition / cannibalisation and LFL pressure to increase over the next 2-3 years and the shares to de-rate. We pitch our forecasts 5%-14% below consensus and initiate with a Sell recommendation and a 145p target price.
Panmure Morning Note 24-02-2017
24 Feb 17
Upgrades and increased shareholder returns were needed to justify the recent share price rally: they have been duly delivered and we expect a positive response today. FY16 was largely ‘in-line’ and initial FY17 comments, for operating profit growth YOY, are encouraging. Our initial estimate is for consensus upgrades of 5-10%. IAG has confirmed a €500m share buy-back programme, which was well flagged and we think in line with market expectations. Overall a welcome, slightly more positive read for the sector, particularly those with self-help levers. Presentation 9am GMT.